8VB1

Crystal structure of HIV-1 protease with GS-9770

This is a non-PDB format compatible entry.

Summary for 8VB1

• Entry DOI: 10.2210/pdb8vb1/pdb
• Descriptor: HIV-1 protease, (2S)-2-{(3M)-4-chloro-3-[1-(difluoromethyl)-1H-1,2,4-triazol-5-yl]phenyl}-2-[(2E,4R)-4-[4-(2-cyclopropyl-2H-1,2,3-triazol-4-yl)phenyl]-2-imino-5-oxo-4-(3,3,3-trifluoro-2,2-dimethylpropyl)imidazolidin-1-yl]ethyl [1-(difluoromethyl)cyclopropyl]carbamate (3 entities in total)
• Functional Keywords: hiv, protease, antiviral, inhibitor, viral protein
• Biological source: HIV-1 06TG.HT043
• Total number of polymer chains: 2
• Total formula weight: 22474.77

Authors

Lansdon, E.B. (deposition date: 2023-12-11, release date: 2024-03-06, Last modification date: 2024-04-17)

• Primary citation: Mulato, A.,Lansdon, E.,Aoyama, R.,Voigt, J.,Lee, M.,Liclican, A.,Lee, G.,Singer, E.,Stafford, B.,Gong, R.,Murray, B.,Chan, J.,Lee, J.,Xu, Y.,Ahmadyar, S.,Gonzalez, A.,Cho, A.,Stepan, G.J.,Schmitz, U.,Schultz, B.,Marchand, B.,Brumshtein, B.,Wang, R.,Yu, H.,Cihlar, T.,Xu, L.,Yant, S.R.; Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.; Antimicrob.Agents Chemother., 68:e0137323-e0137323, 2024; PubMed: 38380945; DOI: 10.1128/aac.01373-23

Experimental method

X-RAY DIFFRACTION (1.3 Å)